Allyx

Revivio Therapeutics

This clinical-stage biotechnology company develops small molecule therapeutics for patients with neurodegenerative diseases, including Alzheimer's disease and mild cognitive impairment.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

NeuroTherapia

This clinical-stage company develops oral small-molecule therapies targeting neuroinflammation for patients with Alzheimer's disease and other neurodegenerative disorders.

PharmatrophiX

The company develops small-molecule therapies targeting neurotrophin receptors for patients with Alzheimer's disease and other neurodegenerative disorders.

AstronauTx

This biotechnology company develops small-molecule drugs targeting astrocyte biology to treat patients with Alzheimer's disease and other neurodegenerative disorders.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Cognition Therapeutics

This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.

BioClec

This biotechnology firm develops therapies targeting brain immune cells to treat patients with Alzheimer's disease.